SA111320572B1 - طريقة تحديد ترتيب pcr معتمدة على تقنية الوسم الجزيئي لحمض dna وإستراتيجية قص غير كامل لحمض dna - Google Patents

طريقة تحديد ترتيب pcr معتمدة على تقنية الوسم الجزيئي لحمض dna وإستراتيجية قص غير كامل لحمض dna Download PDF

Info

Publication number: SA111320572B1
Authority: SA; Saudi Arabia
Prior art keywords: pcr; primer; pairs; dna; hla
Prior art date: 2010-06-30

Application number

SA111320572A

Other languages

Arabic (ar)

English (en)

Inventor

جيان لي

تاو ليو

ميرو زهاو

زياندونج زهانج

Original Assignee

بجاي شنزين كو ليمتد

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2010-06-30

Filing date

2011-07-02

Publication date

2015-04-29

2011-07-02 Application filed by بجاي شنزين كو ليمتد filed Critical بجاي شنزين كو ليمتد

2015-04-29 Publication of SA111320572B1 publication Critical patent/SA111320572B1/ar

Links

238000000034 method Methods 0.000 title claims abstract description 103
238000010008 shearing Methods 0.000 title claims abstract description 33
238000012163 sequencing technique Methods 0.000 title claims abstract description 23
108020004414 DNA Proteins 0.000 claims abstract description 75
238000003205 genotyping method Methods 0.000 claims abstract description 6
239000007858 starting material Substances 0.000 claims description 49
102100028972 HLA class I histocompatibility antigen, A alpha chain Human genes 0.000 claims description 33
108010075704 HLA-A Antigens Proteins 0.000 claims description 33
239000000203 mixture Substances 0.000 claims description 19
108090000623 proteins and genes Proteins 0.000 claims description 13
238000005516 engineering process Methods 0.000 claims description 11
239000002243 precursor Substances 0.000 claims description 11
230000003321 amplification Effects 0.000 claims description 10
238000001962 electrophoresis Methods 0.000 claims description 10
238000003199 nucleic acid amplification method Methods 0.000 claims description 10
239000000126 substance Substances 0.000 claims description 10
108020004707 nucleic acids Proteins 0.000 claims description 9
102000039446 nucleic acids Human genes 0.000 claims description 9
150000007523 nucleic acids Chemical class 0.000 claims description 9
239000000463 material Substances 0.000 claims description 8
108091028043 Nucleic acid sequence Proteins 0.000 claims description 7
238000012408 PCR amplification Methods 0.000 claims description 7
210000004369 blood Anatomy 0.000 claims description 7
239000002253 acid Substances 0.000 claims description 6
239000008280 blood Substances 0.000 claims description 6
238000001712 DNA sequencing Methods 0.000 claims description 5
230000002441 reversible effect Effects 0.000 claims description 5
239000002773 nucleotide Substances 0.000 claims description 4
125000003729 nucleotide group Chemical group 0.000 claims description 3
238000012360 testing method Methods 0.000 claims description 3
108090000790 Enzymes Proteins 0.000 claims description 2
102000004190 Enzymes Human genes 0.000 claims description 2
102100040485 HLA class II histocompatibility antigen, DRB1 beta chain Human genes 0.000 claims description 2
108010039343 HLA-DRB1 Chains Proteins 0.000 claims description 2
238000002156 mixing Methods 0.000 claims description 2
230000000712 assembly Effects 0.000 claims 1
238000000429 assembly Methods 0.000 claims 1
230000003412 degenerative effect Effects 0.000 claims 1
230000000246 remedial effect Effects 0.000 claims 1
238000004458 analytical method Methods 0.000 abstract description 4
102000053602 DNA Human genes 0.000 abstract description 2
239000000047 product Substances 0.000 description 59
101001100327 Homo sapiens RNA-binding protein 45 Proteins 0.000 description 21
102100038823 RNA-binding protein 45 Human genes 0.000 description 21
230000008569 process Effects 0.000 description 18
238000006243 chemical reaction Methods 0.000 description 13
230000008707 rearrangement Effects 0.000 description 12
239000003999 initiator Substances 0.000 description 8
239000012634 fragment Substances 0.000 description 7
238000000746 purification Methods 0.000 description 7
108700024394 Exon Proteins 0.000 description 6
238000001514 detection method Methods 0.000 description 5
238000000605 extraction Methods 0.000 description 5
239000003550 marker Substances 0.000 description 5
239000000499 gel Substances 0.000 description 4
230000002068 genetic effect Effects 0.000 description 4
239000003147 molecular marker Substances 0.000 description 4
102100028976 HLA class I histocompatibility antigen, B alpha chain Human genes 0.000 description 3
108010058607 HLA-B Antigens Proteins 0.000 description 3
230000000052 comparative effect Effects 0.000 description 3
230000002255 enzymatic effect Effects 0.000 description 3
238000006911 enzymatic reaction Methods 0.000 description 3
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
108700028369 Alleles Proteins 0.000 description 2
241000124008 Mammalia Species 0.000 description 2
238000007259 addition reaction Methods 0.000 description 2
230000008901 benefit Effects 0.000 description 2
239000007795 chemical reaction product Substances 0.000 description 2
239000003795 chemical substances by application Substances 0.000 description 2
238000010276 construction Methods 0.000 description 2
238000013461 design Methods 0.000 description 2
238000001502 gel electrophoresis Methods 0.000 description 2
230000008439 repair process Effects 0.000 description 2
230000002194 synthesizing effect Effects 0.000 description 2
229920000936 Agarose Polymers 0.000 description 1
241001504639 Alcedo atthis Species 0.000 description 1
101150019028 Antp gene Proteins 0.000 description 1
102000012410 DNA Ligases Human genes 0.000 description 1
108010061982 DNA Ligases Proteins 0.000 description 1
230000004544 DNA amplification Effects 0.000 description 1
102210048119 DRB1*12:01 Human genes 0.000 description 1
102210012675 DRB1*15 Human genes 0.000 description 1
102210047362 DRB1*15:01 Human genes 0.000 description 1
206010059866 Drug resistance Diseases 0.000 description 1
102000020897 Formins Human genes 0.000 description 1
108091022623 Formins Proteins 0.000 description 1
206010064571 Gene mutation Diseases 0.000 description 1
101150118346 HLA-A gene Proteins 0.000 description 1
241000282412 Homo Species 0.000 description 1
241000283986 Lepus Species 0.000 description 1
102000029749 Microtubule Human genes 0.000 description 1
108091022875 Microtubule Proteins 0.000 description 1
108091000080 Phosphotransferase Proteins 0.000 description 1
101000972349 Phytolacca americana Lectin-A Proteins 0.000 description 1
238000011529 RT qPCR Methods 0.000 description 1
238000012300 Sequence Analysis Methods 0.000 description 1
230000003044 adaptive effect Effects 0.000 description 1
239000003463 adsorbent Substances 0.000 description 1
239000011543 agarose gel Substances 0.000 description 1
238000000246 agarose gel electrophoresis Methods 0.000 description 1
239000000427 antigen Substances 0.000 description 1
108091007433 antigens Proteins 0.000 description 1
102000036639 antigens Human genes 0.000 description 1
238000003556 assay Methods 0.000 description 1
239000011324 bead Substances 0.000 description 1
239000000872 buffer Substances 0.000 description 1
238000012937 correction Methods 0.000 description 1
SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 1
SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 1
238000006731 degradation reaction Methods 0.000 description 1
238000010586 diagram Methods 0.000 description 1
230000009977 dual effect Effects 0.000 description 1
238000010828 elution Methods 0.000 description 1
239000012149 elution buffer Substances 0.000 description 1
238000001976 enzyme digestion Methods 0.000 description 1
239000000835 fiber Substances 0.000 description 1
210000003958 hematopoietic stem cell Anatomy 0.000 description 1
239000007937 lozenge Substances 0.000 description 1
238000007886 magnetic bead extraction Methods 0.000 description 1
238000002844 melting Methods 0.000 description 1
230000008018 melting Effects 0.000 description 1
230000029052 metamorphosis Effects 0.000 description 1
210000004688 microtubule Anatomy 0.000 description 1
230000001343 mnemonic effect Effects 0.000 description 1
238000012986 modification Methods 0.000 description 1
230000004048 modification Effects 0.000 description 1
230000035772 mutation Effects 0.000 description 1
238000007481 next generation sequencing Methods 0.000 description 1
102000020233 phosphotransferase Human genes 0.000 description 1
239000006187 pill Substances 0.000 description 1
238000003752 polymerase chain reaction Methods 0.000 description 1
238000011176 pooling Methods 0.000 description 1
238000002360 preparation method Methods 0.000 description 1
238000012175 pyrosequencing Methods 0.000 description 1
238000011160 research Methods 0.000 description 1
239000007787 solid Substances 0.000 description 1
239000003381 stabilizer Substances 0.000 description 1
210000001562 sternum Anatomy 0.000 description 1
238000006467 substitution reaction Methods 0.000 description 1
101150003509 tag gene Proteins 0.000 description 1
210000001519 tissue Anatomy 0.000 description 1
238000010200 validation analysis Methods 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing

Landscapes

Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Organic Chemistry (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Microbiology (AREA)
Immunology (AREA)
Biotechnology (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Analytical Chemistry (AREA)
Physics & Mathematics (AREA)
Biochemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
General Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

SA111320572A 2010-06-30 2011-07-02 طريقة تحديد ترتيب pcr معتمدة على تقنية الوسم الجزيئي لحمض dna وإستراتيجية قص غير كامل لحمض dna SA111320572B1 (ar)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
CN201010213717.6A CN101921840B (zh)	2010-06-30	2010-06-30	一种基于dna分子标签技术和dna不完全打断策略的pcr测序方法

Publications (1)

Publication Number	Publication Date
SA111320572B1 true SA111320572B1 (ar)	2015-04-29

Family

ID=43337055

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SA111320572A SA111320572B1 (ar)	2010-06-30	2011-07-02	طريقة تحديد ترتيب pcr معتمدة على تقنية الوسم الجزيئي لحمض dna وإستراتيجية قص غير كامل لحمض dna

Country Status (3)

Country	Link
CN (1)	CN101921840B (zh)
SA (1)	SA111320572B1 (zh)
WO (1)	WO2012000152A1 (zh)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2008027558A2 (en)	2006-08-31	2008-03-06	Codon Devices, Inc.	Iterative nucleic acid assembly using activation of vector-encoded traits
CN101921841B (zh) *	2010-06-30	2014-03-12	深圳华大基因科技有限公司	基于Illumina GA测序技术的HLA基因高分辨率分型方法
WO2012083505A1 (zh) *	2010-12-24	2012-06-28	深圳华大基因科技有限公司	Hla-c基因分型的方法及其相关引物
EP2599877B1 (en)	2010-06-30	2017-09-27	BGI Genomics Co., Limited	New pcr sequencing method and use thereof in hla genotyping
CN103502448B (zh)	2010-11-12	2017-03-29	Gen9股份有限公司	核酸合成的方法和设备
US10457935B2 (en)	2010-11-12	2019-10-29	Gen9, Inc.	Protein arrays and methods of using and making the same
CN103270170B (zh) *	2010-12-24	2015-07-29	深圳华大基因医学有限公司	Hla-dqb1基因分型的方法及其相关引物
CN102653784B (zh) *	2011-03-03	2015-01-21	深圳华大基因科技服务有限公司	用于多重核酸测序的标签及其使用方法
CN102690809B (zh) *	2011-03-24	2013-12-04	深圳华大基因科技服务有限公司	Dna标签及其在构建和测序配对末端标签文库中的应用
LT2944693T (lt)	2011-08-26	2019-08-26	Gen9, Inc.	Kompozicijos ir būdai, skirti nukleorūgščių didelio tikslumo sąrankai
US9150853B2 (en)	2012-03-21	2015-10-06	Gen9, Inc.	Methods for screening proteins using DNA encoded chemical libraries as templates for enzyme catalysis
LT2841601T (lt) *	2012-04-24	2019-07-10	Gen9, Inc.	Nukleorūgščių rūšiavimo būdai ir multipleksinis preparatyvinis in vitro klonavimas
EP3483311A1 (en)	2012-06-25	2019-05-15	Gen9, Inc.	Methods for nucleic acid assembly and high throughput sequencing
CN102758026B (zh) *	2012-06-29	2014-05-07	深圳华大基因科技有限公司	基于HiSeq测序技术检测乙型肝炎病毒分型和耐药基因的方法
CN103045591B (zh) *	2013-01-05	2014-03-12	上海荻硕贝肯生物科技有限公司	Hla基因特异性pcr扩增引物及hla分型的方法和试剂盒
WO2015047220A2 (en) *	2013-09-24	2015-04-02	Georgetown University	Compositions and methods for single g-level hla typing
CN103617375B (zh) *	2013-12-02	2017-08-25	深圳华大基因健康科技有限公司	聚合酶链式反应产物测序分型的方法及***
CN111748606A (zh) *	2014-06-24	2020-10-09	北京贝瑞和康医学检验实验室有限公司	一种快速构建血浆dna测序文库的方法和试剂盒
CN104232631B (zh) *	2014-08-26	2017-12-15	深圳华大基因股份有限公司	标签、标签引物、试剂盒及其用途
CN104293941B (zh) *	2014-09-30	2017-01-11	天津华大基因科技有限公司	构建测序文库的方法及其应用
CN104561294B (zh) *	2014-12-26	2018-03-30	北京诺禾致源科技股份有限公司	基因分型测序文库的构建方法和测序方法
CN107858408A (zh) *	2016-09-19	2018-03-30	深圳华大基因科技服务有限公司	一种基因组二代序列组装方法和***
CN106754904B (zh) *	2016-12-21	2019-03-15	南京诺唯赞生物科技有限公司	一种cDNA的特异性分子标签及其应用
CN108728903A (zh) *	2017-04-21	2018-11-02	深圳市乐土精准医疗科技有限公司	基于高通量测序用于地中海贫血大样本筛查的建库方法
CN109801679B (zh) *	2019-01-15	2021-02-02	广州柿宝生物科技有限公司	一种用于长链分子的数学序列重建方法
CN113564228A (zh) *	2021-09-26	2021-10-29	天津诺禾致源生物信息科技有限公司	样本的自动化处理方法及装置、样本的自动化处理***
CN117437978A (zh) *	2023-12-12	2024-01-23	北京旌准医疗科技有限公司	一种二代测序数据的低频基因突变分析方法、装置及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0400584D0 (en) *	2004-01-12	2004-02-11	Solexa Ltd	Nucleic acid chacterisation
JP5237099B2 (ja) *	2005-09-29	2013-07-17	キージーンナムローゼフェンノートシャップ	変異させた集団のハイスループットスクリーニング
WO2008045575A2 (en) *	2006-10-13	2008-04-17	J. Craig Venter Institute, Inc.	Sequencing method
EP2121983A2 (en) *	2007-02-02	2009-11-25	Illumina Cambridge Limited	Methods for indexing samples and sequencing multiple nucleotide templates
WO2009049889A1 (en) *	2007-10-16	2009-04-23	Roche Diagnostics Gmbh	High resolution, high throughput hla genotyping by clonal sequencing
CN101434988B (zh) *	2007-11-16	2013-05-01	深圳华因康基因科技有限公司	一种高通量寡核苷酸测序方法
CN101654691B (zh) *	2009-09-23	2013-12-04	深圳华大基因健康科技有限公司	Hla基因扩增和基因分型方法及其相关引物

2010
- 2010-06-30 CN CN201010213717.6A patent/CN101921840B/zh active Active
- 2010-11-15 WO PCT/CN2010/001834 patent/WO2012000152A1/zh active Application Filing
2011
- 2011-07-02 SA SA111320572A patent/SA111320572B1/ar unknown

Also Published As

Publication number	Publication date
CN101921840B (zh)	2014-06-25
CN101921840A (zh)	2010-12-22
WO2012000152A1 (zh)	2012-01-05

Publication	Publication Date	Title
SA111320572B1 (ar)	2015-04-29	طريقة تحديد ترتيب pcr معتمدة على تقنية الوسم الجزيئي لحمض dna وإستراتيجية قص غير كامل لحمض dna
JP5968879B2 (ja)	2016-08-10	Ｄｎａ分子タグ技術及びｄｎａ不完全断片化技術に基づいたｐｃｒシークエンシング法及びそれを用いたｈｌａ遺伝子タイピング法
US20210363570A1 (en)	2021-11-25	Method for increasing throughput of single molecule sequencing by concatenating short dna fragments
WO2012037882A1 (zh)	2012-03-29	Dna标签及其应用
CN110218781B (zh)	2023-03-31	21个微单倍型位点的复合扩增体系、下一代测序分型试剂盒及分型方法
Yin et al.	2021	Challenges in the application of NGS in the clinical laboratory
WO2012000150A1 (zh)	2012-01-05	Hla-a，b基因分型用pcr引物及其使用方法
Liu et al.	2018	Accurate typing of human leukocyte antigen class I genes by Oxford nanopore sequencing
WO2012037883A1 (zh)	2012-03-29	核酸标签及其应用
WO2012000153A1 (zh)	2012-01-05	基于illuminaga测序技术的hla基因高分辨率分型方法
Grumbt et al.	2013	Diagnostic applications of next generation sequencing in immunogenetics and molecular oncology
CN105039322B (zh)	2018-05-22	Dna标签序列及测序文库构建方法和试剂盒
US10889860B2 (en)	2021-01-12	Compositions and methods for single G-level HLA typing
TW201300528A (zh)	2013-01-01	Ｈｌａ－ｄｑｂ１基因分型的方法及其相關引子
CN112609006B (zh)	2022-08-12	人类白细胞抗原一步测序分型方法及其应用
TWI542696B (zh)	2016-07-21	HLA - C genotyping and its related primers
CN105603052B (zh)	2021-03-19	探针及其用途
CN113544282A (zh)	2021-10-22	基于dna样本构建测序文库的方法及应用
WO2021050717A1 (en)	2021-03-18	Immune cell sequencing methods
MURTHY et al.	2020	Human Saliva and dried saliva spots as source of DNA for PCR based HLA typing using a combination of Taq DNA polymerase and accuprimetaq polymerase
WO2013100139A1 (ja)	2013-07-04	Ｈｌａ－ａ*２４グループの判定方法
Wang et al.	2022	Simultaneous genotyping for human platelet antigen systems and HLA-A and HLA-B loci by targeted next-generation sequencing
KR20210079309A (ko)	2021-06-29	핵산의 바코딩
CN114277096B (zh)	2024-06-04	鉴别地中海贫血αααanti4.2杂合型和HKαα杂合型的方法和试剂盒
Doxiadis et al.	2009	High resolution definition of HLA‐DRB haplotypes by a simplified microsatellite typing technique